Ibrutinib in relapsed chronic lymphocytic leukemia.
John C
JC
Byrd
Susan
S
O'Brien
Danelle F
DF
James
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011720:Pyrazoles; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases